| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.45M | - | |
| CFO | 403.3K | $14.62M | - | |
| Dir | 367.6K | $13.33M | - | |
| VP | 148.8K | $5.40M | - | |
| Dir | 115.7K | $4.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2021 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 6,012 | $10.57 | $63,523.39 | -7.2% | |
| Mar 4, 2021 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 7,513 | $10.58 | $79,520.60 | -27.0% | |
| Mar 4, 2021 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 13,930 | $10.57 | $147,185.77 | -82.4% | |
| Mar 3, 2021 | Nazzi Gianfranco | EVP, International Markets | Sale+OE | 1,400 | $10.88 | $15,231.44 | -100% | |
| Mar 3, 2021 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 606 | $10.86 | $6,582.74 | -0.9% | |
| Mar 3, 2021 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 993 | $10.88 | $10,803.44 | -7.7% | |
| Mar 3, 2021 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 15,548 | $10.85 | $168,630.73 | -33.8% | |
| Mar 2, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sell | 50,000 | $10.82 | $540,890.00 | -43.8% | |
| Mar 1, 2021 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 18,430 | $10.83 | $199,611.64 | -86.1% | |
| Mar 1, 2021 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 73,127 | $10.91 | $798,022.67 | -37.3% |